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Review Article
Posterior Reversible Encephalopathy Syndrome
Courtney M. Schusse, M.D., Alicia L. Peterson, M.D., Jason P. Caplan, M.D.
Background: The presentation of posterior reversible
encephalopathy syndrome (PRES) features neuropsychiat-
ric symptoms in the context of predominantly white matter
cerebral edema in the setting of a diverse variety of under-
lying clinical entities. Objective: To illustrate the presen-
tation and diagnostic strategy for this under-recognized
condition. Method: We present two cases of PRES and
review the available literature. Results: PRES may be due
to a number of underlying conditions, but typically pres-
ents with symptoms consistent with delirium. Conclusions:
Psychiatrist practicing in the general hospital should
be aware of the presentation and appropriate work-up
of PRES to forestall serious potential sequelae.
(Psychosomatics 2013; 54:205–211)
Posterior reversible encephalopathy syndrome (PRES)is a condition that may present with a variety of neu-
ropsychiatric signs and symptoms and is characterized by
a pattern of abnormalities on brain imaging studies. PRES
has occurred in the context of a spectrum of underlying
clinical entities that affect blood pressure and permeability
of the cerebral vasculature. Psychiatrists practicing in the
general hospital setting should be aware of this phenom-
enon and the importance of differentiating it from other
causes of delirium. Here, we present the cases of two
patients who presented with PRES and review the current
literature on pathophysiology, diagnosis, and treatment.
Case 1
Ms. A, a 22-year-old woman with no significant past
medical history, was brought to our hospital by ambulance
at 28 weeks of pregnancy after she was found at home by
her mother with generalized tonic-clonic seizure activity.
En route to the hospital, blood pressure was found to be
elevated to 176/106 mmHg (range: 148–176/98–106 mmHg).
She had one additional seizure in the emergency room, and
was obtunded on exam; initial treatment consisted of in-
travenous magnesium, blood pressure control with labeta-
lol and, ultimately, delivery of her infant by emergency
cesarean section. Magnetic resonance imaging (MRI) of her
brain was obtained, which showed patchy T2 hyperintense
white matter lesions consistent with a diagnosis of PRES
secondary to eclampsia (Figure 1). An EEG was obtained on
the day of admission, showing a predominant mixture of
alpha and beta, but with theta and delta frequencies as well.
There was only a brief period of wakefulness, and Ms. A was
described as being “stuporous” by the technician performing
the test. Postoperatively, Ms. A remained somewhat lethar-
gic, but was arousable and oriented. She had no additional
seizures in the hospital. MRI at 6-month follow-up showed
resolution of the lesions (Figure 2) and her blood pressure
was normal (122/79 mmHg).
Case 2
Ms. B, a 55-year-old woman with a history of hyper-
tension and both chronic back and abdominal pain, pre-
sented to our hospital with sudden onset of confusion,
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lethargy, and elevated blood pressure to 183/78 mmHg.
She was admitted to the intensive care unit and continued
to exhibit fluctuating attention, consistent with delirium.
MRI of the brain revealed diffuse patchy, subcortical
white matter T2 and fluid attenuated inversion recovery
(FLAIR) hyperintensities, consistent with PRES second-
ary to hypertensive emergency (Figure 3). An EEG was
obtained, showing theta activity, admixed with polymor-
phic delta and frontal intermittent rhythmic delta activity
(FIRDA) consistent with delirium. Ms. B’s mental status
slowly improved over the course of her 4 days in the
hospital, returning to her baseline of function prior to
discharge. Repeat MRI 4 months after discharge demon-
strated resolution of the lesions (Figure 4). At that time,
Ms. B was alert and oriented, with normal blood pressure
(114/67 mmHg).
DISCUSSION
In the cases of PRES described above, Ms. A developed
generalized tonic-clonic seizures, and thus was immediately
recognized as requiring medical attention; however, the more
common and insidious scenario is that of Ms. B, in which a
patient presents with confusion or delirium as the chief clin-
ical symptom. The original nomenclature of reversible pos-
terior leukoencephalopathy syndrome (abbreviated RPLE or
RPLS), first described in 1996 by Hinchey et al,1 has fallen
out of use in favor of PRES, since lesions are not always
confined to white matter. This designation too, may ulti-
mately prove to be a misnomer, as this syndrome has been
increasingly recognized in other regions of the brain and in
some cases is not entirely reversible.
FIGURE 1. MRI Brain Axial Fluid Attenuation Recovery (FLAIR) Images Showing White Matter Lesions in the Bifrontal, Biparietal and
Left Occipital Lobes.
FIGURE 2. 6 Month Follow Up: MRI Brain Axial FLAIR Images Showing Complete Resolution of Lesions.
PRES
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The syndrome was originally recognized in the setting of
severe hypertension, eclampsia, or with the use of cyclospo-
rine or other immunosuppressants; however, the underlying
mechanism is still a subject of some controversy.1,2 Classi-
cally, MRI of the brain (PRES is less easily recognized on
computed tomography [CT]) will typically demonstrate sym-
metric, posterior occipital/parietal/temporal predominantly
white matter edema, although a number of cases with atypical
locations or asymmetric lesions have been reported.1–3 Re-
ports of frontal lesions have become increasingly common,
and lesions consistent with PRES have also been found in
occurring in the brainstem and basal ganglia.2
Clinically, the presentation may be nonspecific, but
altered mentation is a nearly universal symptom, ranging
from confusion and lethargy to stupor.4,5 Seizures, head-
aches, and visual disturbances (including formed visual
hallucinations and visual field cuts) are also common.
Diagnosis of PRES is confirmed by MRI showing the
characteristic edema. With aggressive and appropriate treat-
ment, patients with PRES are likely to completely recover,
and imaging changes are expected to resolve. If PRES is not
aggressively and expediently managed, more deleterious out-
comes are possible, with reports of progression to ischemia,
frank infarction, and occasionally death.6–8
Epidemiology
By its nature as a radiographic diagnosis, PRES is not
isolated to one clinical entity or diagnosis. It is most
commonly reported in cases of hypertensive encephalop-
athy. Reports to date indicate no clear male/female pre-
dominance; however, by virtue of gender-specific condi-
FIGURE 3. Initial MRI Brain Axial FLAIR With Extensive Subcortical White Matter Lesions Involving all Lobes Bilaterally, as well as
the Right Cerebellum (Not Pictured). Note that all Lesions Spare the Gray Matter of the Cortex.
FIGURE 4. 4 Month Follow Up: MRI Brain Axial FLAIR Images Showing Complete Resolution of Lesions. The Patient Does have a Few
Areas of Non-specific White Matter Changes, Consistent With Chronic Small Vessel Disease, Likely Related to Her Underlying
Hypertension.
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tions that can result in hypertensive encephalopathy (i.e.,
eclampsia), females tend to predominate in most case se-
ries. Patients with renal failure and those taking immuno-
suppressant or cytotoxic medications (especially calcineu-
rin inhibitors) are especially susceptible.2,4 Conditions
with metabolic imbalances or fluid overload may predis-
pose to PRES via blood pressure lability and elevation.1
In one large retrospective case series, males and fe-
males were represented almost equally (53% women, 47%
males). Hypertension was overwhelmingly the most com-
mon risk factor, present in 68% of cases.4 The average age
was 45 years, with younger patients mostly representing
cases of calcinuerin inhibitor (e.g., tacrolimus, cyclospo-
rine) use.4
Pathophysiology
The precise mechanism of PRES remains obscure.
Although a few hypotheses have been cited, controversy
still abounds. While a detailed evaluation of the proposed
mechanisms is beyond the scope of this review, a brief
description of the prevailing hypotheses is warranted.
There are two major theories espoused in the literature: (1)
sudden hypertension leads to failure of autoregulation fol-
lowed by vasodilation and edema; and (2) vasoconstriction
leading to ischemia and ultimately edema.1,9–11
Failure of Autoregulation
Cerebral autoregulation is a function of the normal
brain vasculature that compensates for fluctuations in
blood pressure (either increased or decreased) in order to
maintain stable blood flow to the brain.10 Under normal
conditions, within a range of blood pressures, vasodilation
(in response to low blood pressure), and vasoconstriction
(in response to high blood pressure) act to maintain con-
stant cerebral circulation.4,10,11 In the setting of severe
hypertension, autoregulation fails and arterioles dilate,
leading to transudation of fluid, injury to capillaries, hy-
perperfusion and, ultimately, vasogenic edema.1,10 This
theory would seem to be supported by the increase of
water diffusion seen with the typical imaging lesions of
PRES.11 Though no large clinical series exist, the auto-
regulatory hypothesis has been supported by data from
animal model studies and from isolated clinical cases
where PRES lesions were studied with single-photon
emission CT.4 It is not entirely clear why PRES favors the
posterior regions of the brain, but it has been postulated
that the relative paucity of sympathetic innervation in the
posterior circulation leads to greater inability to withstand
perturbations of the cerebral autoregulatory mechanism.11
Vasoconstriction
Vasoconstriction as a mechanism for PRES was the
initial theory proposed based upon numerous underlying
conditions where the characteristic lesions were known to
occur, including pre-eclampsia and chemotherapy.1,10
These pathophysiologic mechanisms are better under-
stood, allowing for extrapolation to the hypothesis that
PRES represents a cascade of events caused by endothelial
dysfunction. Cyclosporine, for example, exerts a direct
toxic effect on vascular endothelium, affecting the blood
brain barrier and prompting endothelial cells to release
endothelin—a potent vasoconstrictor.1 Moreover, in pre-
eclampsia, the inciting event is widely considered to be
endothelial activation and injury, and the diffuse activation
of endothelium leads to systemic vasoconstriction.10 Of
note, PRES has been shown to develop in patients with
only mild elevation in blood pressure or in those who are
normotensive,4,10 adding credence to the idea that hyper-
tension is not the inciting cause. In the vast majority of
patients who develop PRES, regardless of the systemic
process (e.g., chemotherapy-induced hypertension, ec-
lampsia), the underlying biology is similar—endothelial
dysfunction with systemic vasoconstriction, and hypoper-
fusion.1,10 Sustained hypoperfusion leads to vasogenic
edema through a complex mechanism of up-regulation of
factors affecting vascular permeability.10
Imaging
As the name PRES suggests, CT or MRI of the brain
typically reveals focal edema of the white matter, especially
the parieto-occipital regions.1,4 However, PRES is not en-
tirely a posterior phenomenon, as other regions including the
frontal lobes (one series reported involvement in nearly 80%
of their cases),12 temporal-occipital junction, and cerebellum
can also be involved.2 There have been rare cases of PRES
involving the brainstem.12 In the occipital lobes, the parame-
dian and calcarine regions are usually spared, aiding in the
differentiation from bilateral posterior cerebral artery infarc-
tion.1 Lesions are typically bilateral, fairly symmetrical, and
mostly involve white matter,1,11 but there have been atypical
cases of unilateral lesions, hemorrhage, or gray matter in-
volvement, although these are rare.1,4
MRI studies are most useful diagnostic tests, with
lesions most conspicuous with FLAIR imaging, especially
PRES
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in cases of more subtle lesions that may be missed on the
low resolution of CT.4 Diffusion weighted imaging
(DWI), with supplemental apparent diffusion coefficient
(ADC) map images also aid in distinguishing the vaso-
genic edema of PRES (bright on both DWI and ADC), vs.
cytotoxic edema associated with ischemic infarcts (bright
on DWI, dark on ADC).2,4 Table 1 summarizes the dif-
ferential diagnosis of white matter T2 hyperintense le-
sions. There have been, however, some reports of foci of
irreversible ischemia associated with PRES in addition to
the traditional reversible vasogenic edema.4
Laboratory Data
Given the wide range of systemic and metabolic con-
ditions that predispose to PRES, there is no specific lab-
oratory test available. Studies of pre-eclampsia/eclampsia
demonstrate that there is often evidence of endothelial
injury based upon findings of platelet consumption and the
presence of schistocytes.2 Similar laboratory findings have
been noted in cases of PRES associated with sepsis and
shock.2
Clinical Presentation
Table 2 details some of the more common conditions
that predispose to the development of PRES. The most
common clinical symptoms and signs are detailed in Table
3. The onset of symptoms is usually subacute, with alter-
ations in mentation developing over several days, but may
be recognized more acutely if the patient has seizures.1,5 In
about 70% of patients, moderate or severe hypertension
may be seen.2 Seizures may be present at onset, but can
also develop later in the course. Seizures may have focal
onset, but generalized tonic-clonic activity is most often
reported, with multiple seizures being more common than
single events.2,5 Patients invariably exhibit alterations in
consciousness, with most presenting with lethargy and
somnolence, though restlessness, agitation, and frank de-
lirium are also common.2 Stupor and coma may develop,
but most patients remain at least somewhat responsive to
stimuli.2 Memory is usually impaired to some degree.
Visual abnormalities are also frequently noted with pa-
tients reporting blurred vision or exhibiting visual neglect
and cortical blindness.2,5
A clinically important differential diagnosis of PRES
is that of progressive multifocal leukodystrophy (PML). In
both cases, patients may present with neuropsychiatric
symptoms, but in the case of PML, the onset is usually
insidious and presents with motor signs and dementia
rather than delirium.
Electroencephalography
While generalized slowing on EEG has been noted as
the hallmark of delirium, the EEG findings in PRES are
usually nonspecifically abnormal. In one series of 17 pa-
tients, 13 patients showed diffuse theta and delta slowing,
with two patients with periodic lateralized epileptiform
discharges (PLEDs);13 another series of 28 patients
showed 22 patients with slowing on EEG, three patients
with focal sharp waves and three which were normal.14 A
TABLE 1. Differential of Magnetic Resonance Imaging (MRI)
T2 White Matter Hyperintense Lesions
Neoplasm
● glioma, lymphoma, gliomatosis cerebri, metastasis
Vascular
● PRES, AVM, vasculitis, amyloid angiopathy
Infection
● JC virus (PML), VZV, HIV
Demyelination
● MS, ADEM, leukodystrophy, Balos concentric sclerosis, Marburg
Trauma
● axonal injury
Inflammatory
● sarcoid, Behcet, Sjogren, SLE
Misc.
● Toxic (radiation, drugs), genetic syndromes (Myotonic dystrophy)
TABLE 2. Conditions Predisposing to Posterior Reversible
Encephalopathy Syndrome (PRES)
Pre-eclampsia/eclampsia
Post-transplantation
allogenic-bone marrow transplantation
solid organ transplantation
Immune suppression/chemotherapy
Cyclosporine
Tacrolimus
Cisplatin*
Avastin*
Cytarabine*
Infection/sepsis/shock
Autoimmune disease
SLE
Wegener’s granulomatosus
Polyarteritis nodosa
Miscellaneous(reported associations)
Hypomagnesemia
Dialysis
Hypercalcemia
* Reported associations.
Schusse et al.
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small series in children showed continuous focal rhythmic
slowing in the area of involvement, some with spike and
wave discharges.15 In all cases, the EEG abnormalities
resolved as the clinical manifestations improved.13–15
Pathologic Findings
Though it can be fatal, most cases of PRES do not
lead to death; therefore, histopathologic evaluation of
PRES is uncommon and, if obtained, may only represent
an advanced course of the process. Cases of biopsy or
autopsy during the acute phases have demonstrated vaso-
genic edema in the regions of DWI changes on MRI.2
There are also activated or reactive astrocytes, macro-
phages, and lymphocytes, often without any inflammation,
ischemia, or clear neuronal injury or vascular wall dam-
age.2,9
In cases of PRES after cardiac transplantation, brain
biopsy has shown similar findings of endothelial activa-
tion, diffuse vasogenic edema, reactive astrocytes, and
reactive microglia.16 Nonselective T cell trafficking with
both helper (CD4) and cytotoxic (CD8) subtypes has been
demonstrated but, interestingly, no B cell involvement,
macrophages, or lymphocyte accumulation.16
Autopsy studies late in the process demonstrate some
demyelination, ischemia, neuronal damage, necrosis, and
hemorrhage in the involved white matter as well as the
cortex.2
Treatment
As with other causes of delirium, definitive treatment
of PRES is aimed at identifying and ameliorating the
underlying cause. Correction of systolic blood pressure is
necessary to prevent worsening of the cerebral edema,
though caution must be exercised in certain groups, such
as pregnant women, where rapid decreases in blood pres-
sure may lead to compromised placental flow.5
Though no consensus exists, several sources recom-
mend the institution of antiepileptic therapy. Selection of
therapy clearly depends upon a number of factors, includ-
ing pregnancy and concern for status epilepticus. Magne-
sium sulfate is considered the drug of choice for treatment
in pregnancy.5 At this time, no data exist on the recom-
mended duration of antiepileptic drug therapy.
The prognosis in the majority of patients with PRES
is favorable as most cases do completely resolve as the
name suggests. Some cases involve frank ischemia, with
progression to infarction often correlated to the extent of
T2 and DWI abnormalities on imaging.17 The occurrence
of hemorrhage has been found to be higher in patients with
PRES who had undergone allogenic bone marrow trans-
plant.18
CONCLUSION
PRES has been recognized since 1996 as a distinct syn-
drome. Though it occurs in patients with a variety of
complex systemic and metabolic conditions, the neuroim-
aging findings are characteristic of the condition. The spe-
cific pathogenesis remains unclear, and further research on
this condition is needed. Nonetheless, it is clear that mis-
diagnosis or delay in treatment may result in permanent
neurologic injury or even death.
Given the nonspecific constellation of symptoms as-
sociated with PRES, it is likely an under-recognized cause
of neuropsychiatric symptoms in the acute hospital setting.
Currently, there is little mention of this condition in the
psychiatric literature, but because of the overlap of symp-
tomatology that includes delirium and may potentially
TABLE 3. Case Series of PRES and Their Presenting Signs and Symptoms
Hinchey (1996)1 Bartynski (2006)8 Lee (2008)4 Fugate (2010)17 McKinney (2007)12
n  15 n  25 n  38 n  113 n 7 6
Symptom
Confusion 73% (11) 40% (10) 92% (35) 28% (32) 13% (10)
Headache 53% (8) 28% (7) 53% (20) 26% (29) 4% (3)
Vision abnormalities (e.g., loss, hemianopsia,
cortical blindness
67% (10) 20% (5) 39% (15) 20% (23) 4% (3)
Seizures 73% (11) 64% (16)c 87% (33)b 74% (84) 76% (58)
36% (9)a
a Patients who presented with seizures initially.
b Focal onset in 10 patients.
c Patients that ultimately had seizure during course of acute illness.
PRES
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mimic primary psychiatric illness, it is important that psy-
chiatrists practicing in the general hospital setting are fa-
miliar with this syndrome in order to aid in timely diag-
nosis and appropriate treatment.
Disclosure: J.P.C. is a member of the speakers’
bureau for, has consulted to, and owns stock in Avanir
Pharmaceuticals. C.M.S. and A.L.P. have nothing to
disclose.
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